Nano-X Imaging Ltd. (NNOX) stock soared 16% intraday on Monday, following a bullish analyst report that initiated coverage on the medical imaging technology company with a Buy rating.
D. Boral Capital analyst Jason Kolbert initiated coverage on Nano-X Imaging with a Buy rating and a $23 price target. Kolbert cited the company's innovative Nanox.ARC digital X-ray technology as a disruptive force in the medical imaging market, positioning Nano-X at the forefront of making early cancer detection more accessible and affordable.
The analyst's optimism about Nano-X Imaging's prospects and potential for growth in the rapidly evolving medical imaging space fueled investor enthusiasm, driving the stock's significant intraday surge.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。